跳至主要内容
临床试验/NCT00166127
NCT00166127终止3 期

Pharmacokinetics and Pharmacodynamics of Levosimendan During Cardiac Surgery

Emory University1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2005年5月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
1
试验地点
1
主要终点
pharmacokinetics

研究概览

简要总结

The purpose of this study protocol is to evaluate the blood concentrations of levosimendan when administered at different doses clinically employed during cardiopulmonary bypass or cardiac manipulation during off pump surgery in patients who require the drug for inotropic support (improved heart function) and the associated hemodynamic variables (vital signs). Levosimendan is one of the first agents in a new class of drugs used to treat heart failure and works via a unique mechanism called calcium sensitization, that makes the heart beat more efficiently. Levosimendan also has unique effects on the blood vessels, as well as causing relaxation, an important therapeutic approach of heart failure therapy.

详细描述

This is a non-randomized trial, and the patients will be assigned to one of three dose groups following cardiopulmonary bypass or prior to manipulation of the heart in the off pump group. A total of 30 patients will be enrolled into this study, 20 off-pump and 10 subjects on pump. Levosimendan is approved in Europe for the treatment of decompensated heart failure. It improved cardiac function without increasing energy demands. The subject's enrollment ends at Day 7 or day of discharge, whichever comes first.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •At least 21 years of age
  • •Less than 80 years of age
  • •ASA Class III-IV
  • •Scheduled for elective cardiac surgery
  • •Signed informed consent
  • •History of heart failure, and/or left ventricular ejection fraction <50%

排除标准

  • •Emergency surgery
  • •Withdrawal of consent
  • •Uncontrollable ventricular arrhythmias
  • •Obstructive cardiomyopathy
  • •Confirmed pregnancy test for women of child-bearing potential

结局指标

主要结局

pharmacokinetics

时间窗: day of surgery

次要结局

  • hemodynamics(day of surgery)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验